How partnerships work
Biogen Idec is committed to innovation in everything we do, including partnerships. Because we believe that each partnership or alliance is unique, we are extremely flexible about the structure. In our history, we have engaged in many different kinds of collaborations, licenses and acquisitions.
We enthusiastically engage with our partners at every stage of a product's development. Often, a potential partner is based at a university, with an exciting idea that is nonetheless too conceptual for other sources of funding. Others are in late-stage development and looking for assistance with manufacturing or commercialization.
That's why we have developed a continuum of partnership models specially designed to support companies at different stages. Our Business Development group is focused on late-stage partnerships. Our New Ventures group invests strategically in pre-clinical or Phase 1 products. Our bi3 group works as an incubator for concepts that are still at the proof-of-concept stage.
In each case, we provide support customized to the specialized needs of our partner. And in each case, we work collaboratively with our partner to help ensure success.
How can we best serve our partners?
For many potential partners, Biogen Idec provides an ideal combination of deep resources and personal attention. We can provide assistance at all mileposts in the commercialization process, from clinical development to FDA approval to manufacturing to marketing. Every partnership receives the attention it deserves.
Biogen Idec offers strong expertise in neurology, oncology, immunology and acute care, including cardiovascular, hemophilia, infectious disease, and other hospital-based therapeutic areas. We are interested in alliances that strengthen these existing franchises, as well as additional therapeutic areas that lend themselves to a specialty biopharma business model.
